Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)
Clinical trial NCT06400264 · WITHDRAWN
Trial details
- NCT number
- NCT06400264
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2023-01-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.